A new molecular imaging method can monitor the level and location of gene expression everywhere in the brain, enabling early assessment of gene therapy for brain disease, according to findings presented on Sunday at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) conference. {read more here}